Eisai
4523.T
#2184
Rank
A$12.77 B
Marketcap
A$45.28
Share price
0.11%
Change (1 day)
-0.93%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.31. an increase over its 2024 EPS that were of A$1.47.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.6511.85%
2024A$1.47-32.63%
2023A$2.195.52%
2022A$2.07-74.01%
2021A$7.98-66.58%
2020A$23.8798.24%
2019A$12.0417.01%
2018A$10.2937.78%
2017A$7.47-27.62%
2016A$10.3235.33%
2015A$7.62-2.82%
2014A$7.85-27.66%
2013A$10.85-27.49%
2012A$14.96-12.67%
2011A$17.1388.08%
2010A$9.11-11.06%
2009A$10.24-390.15%
2008A-$3.53-127.78%
2007A$12.7111.78%
2006A$11.374.38%
2005A$10.897.4%
2004A$10.1443.03%
2003A$7.0925.09%
2002A$5.6752.67%
2001A$3.7169.76%
2000A$2.19